glp-1 drugs and anxiety medications used to treat diabetes obesity may also help alleviate symptoms of and depression Association between GLP-1 receptor agonist
Description
Chen WM, Ng HJ, Jao AT, Wu SY, Soong RS
00014-3/asset/c6c68f71-1303-4dbd-81fc-c7e57d64925d/main.assets/gr2_lrg.jpg)
Participants were patients with class II or III obesity treated with either MBS or GLP-1 RAs who were enrolled in Highmark insurance for at least 6 months prior to index treatment and had follow-up data available for at least 12 months
Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment
The result is high quality health care that is accessible, comprehensive, and, most of all, personalized
